[Beta 2 agonists in asthma therapy should be reevaluated--concerning the dosage].
Enheten för lungfysiologi, IFL, arbetsmiljöinstitutet, Solna.
K
K
Larsson
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage* / Q000009:adverse effects; D001249:Asthma / Q000188:drug therapy* / Q000401:mortality; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D005280:Fenoterol / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans
D000318:Adrenergic beta-Agonists; D005280:Fenoterol
Beta 2-agonisternas plats i astmaterapin bör omvärderas--vad gäller dosering.